Trial Profile
A Study to Evaluate the Impact of Summer Vacation on Visual Acuity and Spectral Domain Optical Coherence Tomography of Wet Age Related Macular Degeneration (AMD) Patients Treated With Ranibizumab
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 27 Jun 2016
Price :
$35
*
At a glance
- Drugs Ranibizumab (Primary)
- Indications Age-related macular degeneration
- Focus Therapeutic Use
- 27 Jun 2016 New trial record